Bruker (BRKR) Divestments (2013 - 2014)

Bruker's (BRKR) quarterly Divestments came in at $12.5 million in Q4 2014, up 3.31% quarter-over-quarter from $12.1 million in Q3 2014.

Analysis

Bruker (BRKR) Divestments (2013 - 2014) Analysis & Trends

Bruker (BRKR) has reported Divestments for 2 consecutive years, with $12.5 million the latest figure, recorded in Q4 2014.

For the quarter ending Q4 2014, Divestments changed N/A year-over-year to $12.5 million; the trailing twelve-month figure through Dec 2014 stood at $25.3 million (up 4960.0% YoY), and the FY2015 full-year result was $200000.0, down 99.21% from the prior year.
Divestments advanced to $12.5 million in Q4 2014 per BRKR's latest filing, from $12.1 million in the prior quarter.
Across five years, Divestments topped out at $12.5 million in Q4 2014 and bottomed at $500000.0 in Q1 2013.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Thermo Fisher Scientific	223.12 Bn	219.06 Bn	8.34 Bn	-
2	Danaher	141.96 Bn	137.61 Bn	3.61 Bn	-
3	Agilent Technologies	40.23 Bn	38.47 Bn	1.04 Bn	-
4	Illumina	30.66 Bn	29.50 Bn	770.00 Mn	-
5	Revvity	13.52 Bn	12.50 Bn	416.87 Mn	-
6	Bio-Techne	11.27 Bn	11.00 Bn	211.39 Mn	1.42 Mn
7	Bio-Rad Laboratories	9.93 Bn	8.31 Bn	345.80 Mn	-
8	Repligen	9.22 Bn	8.20 Bn	110.04 Mn	-
9	10x Genomics	8.70 Bn	8.15 Bn	112.50 Mn	-
10	Bruker	8.13 Bn	7.91 Bn	416.00 Mn	-

Historic Data

Download Data